Table 2.
Docetaxel + placebo | Docetaxel + PPV | |
---|---|---|
Prevaccination | ||
N | 24 | 26 |
2 peptide-specific IgGs | 1 | 3 |
3 peptide-specific IgGs | 1 | 4 |
4 peptide-specific IgGs | 22 | 19 |
Postvaccination | ||
N | 22 | 25 |
Humoral responder | 1 | 14 |
Cellular responder | Not examined | 14 |
Positive skin reaction | 4 | 13 |